EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ClouDr Group's enterprise value is HK$1,647 Mil.
ClouDr Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,037 Mil. Therefore, ClouDr Group's EV-to-Revenue for today is 0.41.
The historical rank and industry rank for ClouDr Group's EV-to-Revenue or its related term are showing as below:
HKSE:09955'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.21 Med: 0.54 Max: 11.84
Current: 0.41
During the past 5 years, the highest EV-to-Revenue of ClouDr Group was 11.84. The lowest was 0.21. And the median was 0.54.
HKSE:09955's EV-to-Revenue is ranked better than 60.82% of 97
companies
in the Medical Distribution industry
Industry Median: 0.6
vs HKSE:09955: 0.41
As of today (2024-05-16), ClouDr Group's stock price is HK$3.31.
ClouDr Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$7.46. Therefore, ClouDr Group's PS Ratio for today is 0.44.
ClouDr Group EV-to-Revenue Historical Data
The historical data trend for ClouDr Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClouDr Group's EV-to-Revenue
For the Medical Distribution subindustry, ClouDr Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClouDr Group's EV-to-Revenue Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ClouDr Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ClouDr Group's EV-to-Revenue falls into.
ClouDr Group's current Enterprise Value is HK$1,647 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,037 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClouDr Group (HKSE:09955) EV-to-Revenue Explanation
ClouDr Group's share price for today is HK$3.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$7.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClouDr Group EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ClouDr Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09955 has been successfully added to your